Holen Sie sich die Stockscreener-App
99.50
3.58%
3.365
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt RVTY?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Revvity Inc Aktie (RVTY) Neueste Nachrichten
What drives Revvity Inc. stock priceHigh-yield capital appreciation - Autocar Professional
Wall Street's Insights Into Key Metrics Ahead of Revvity (RVTY) Q2 Earnings - Yahoo Finance
What analysts say about Revvity Inc. stockFree Popular Stock Recommendations - Autocar Professional
Revvity Inc. Stock Analysis and ForecastRobust investment performance - jammulinksnews.com
Investors Interested In Revvity, Inc.'s (NYSE:RVTY) Earnings - simplywall.st
Is Revvity Inc. a good long term investmentAccelerated investment success - Autocar Professional
Revvity (RVTY) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release - Yahoo Finance
Thermo Fisher, Exact Sciences, Integer Holdings, Revvity, and 10x Genomics Shares Are Falling, What You Need To Know - TradingView
How the (RVTY) price action is used to our Advantage - news.stocktradersdaily.com
Earnings Preview: What to Expect From Revvity's Report - MSN
YieldBoost Revvity To 8.9% Using Options - Nasdaq
Ex-Dividend Reminder: Williams Sonoma, Revvity and Zoetis - Nasdaq
Revvity, Inc. Q2 2025 Earnings Preview: Market Expectations and PredictionsNews and Statistics - IndexBox
Revvity Dividend and Company Updates: Key Insights Before Jul 18, 2025 - AInvest
Revvity Inc. Stock Slides 3.0%, Underperforms Market - 富途牛牛
Earnings Preview: What To Expect From Revvity's Report - Barchart.com
Reflecting On Research Tools & Consumables Stocks’ Q1 Earnings: Revvity (NYSE:RVTY) - Yahoo Finance
Revvity (RVTY) Shares Soar 1.98% on Clinical Trial Success - AInvest
Evercore ISI Adjusts Price Target on Revvity to $115 From $116, Maintains Outperform Rating - MarketScreener
(RVTY) Trading Advice - news.stocktradersdaily.com
Revvity to Hold Earnings Call on Monday, July 28, 2025 - Business Wire
Should You Investigate Revvity, Inc. (NYSE:RVTY) At US$101? - simplywall.st
5 Insightful Analyst Questions From Revvity’s Q1 Earnings Call - Yahoo Finance
What 9 Analyst Ratings Have To Say About Revvity - Benzinga
Barclays Keeps Their Buy Rating on Revvity (RVTY) - The Globe and Mail
Is Revvity Stock Underperforming the Dow? - MSN
Is Revvity Stock Underperforming the Dow? A Case for Undervaluation and Growth - AInvest
Leerink Partners Adjusts Price Target on Revvity to $130 From $135, Maintains Outperform Rating - MarketScreener
An Intrinsic Calculation For Revvity, Inc. (NYSE:RVTY) Suggests It's 39% Undervalued - Yahoo Finance
Revvity Inc. stock outperforms competitors despite losses on the day - MarketWatch
How To Trade (RVTY) - news.stocktradersdaily.com
Are Revvity, Inc.'s (NYSE:RVTY) Mixed Financials Driving The Negative Sentiment? - simplywall.st
Revvity introduces new IVD reference standards for monitoring oncology diagnostic testing workflows - SelectScience
Revvity Inc. stock outperforms competitors on strong trading day - MarketWatch
Revvity at Goldman Sachs Conference: Diagnostics and Software Focus By Investing.com - Investing.com Canada
Revvity at Goldman Sachs Conference: Diagnostics and Software Focus - Investing.com
Transcript : Revvity, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-10-2025 08 - MarketScreener
Revvity To Present At Goldman Sachs Global Healthcare Conference; Webcast At 8:00 AM ET - Nasdaq
Wellington Management Group LLP Has $743,000 Stock Holdings in Revvity, Inc. (NYSE:RVTY) - Defense World
(RVTY) Long Term Investment Analysis - news.stocktradersdaily.com
2.94%
1.48%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):